RBI & SEBI

Company secretary Vineet Gawankar steps down from his role at Gujarat Themis Biosyn

Originally reported by scanx.trade as: Gujarat Themis Biosyn company secretary Vineet Gawankar resigns

15 Nov 2026, 6:30 am IST · Xecute.finance News DeskArchive edition

The crisp read

Vineet Gawankar has formally resigned from his position as company secretary at Gujarat Themis Biosyn. The corporate announcement details the departure of the key managerial personnel from the organization. Further details regarding his successor or the exact effective date of departure are not stated in the item.

Xecute Impact Breakdown

For CAs

  • Monitor official stock exchange filings for the announcement regarding the appointment of a new company secretary and the formal transition timeline
  • Keep track of any interim arrangements put in place by the board to manage statutory duties
  • Verify regulatory filing updates due to leadership changes in compliance roles

For businesses

  • Vineet Gawankar has submitted his resignation from the post of company secretary at Gujarat Themis Biosyn
  • Ensure timely notifications are made to stock exchanges and corporate registries regarding changes in this office to maintain transparency

Deep dive – the full story

Vineet Gawankar has submitted his resignation from the post of company secretary at Gujarat Themis Biosyn. The departure marks a change in the key managerial personnel responsible for overseeing corporate governance, regulatory filings, and legal compliance within the firm. In corporate structures, the company secretary acts as the primary link between the board of directors, shareholders, and regulatory authorities, ensuring adherence to statutory guidelines and listing obligations.

Changes in this office require timely notifications to stock exchanges and corporate registries to maintain transparency. Compliance professionals and investors should monitor official exchange filings for announcements regarding the appointment of a new company secretary and the formal transition timeline. Keep track of any interim arrangements put in place by the board to manage statutory duties.

Bottom line: leadership changes in compliance roles require careful verification of regulatory filing updates.

Source: news.google.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the archive edition.

This story has retired from the live feed - the full text stays here permanently. The live app adds the newest desk, Ask Xecute, deadline trackers and the daily quiz.

Open this story in the Xecute app →